BAO PHARMA-B
0265918AListed醫療健康 · 一家专注于大容量皮下给药、抗体介导自身免疫、辅助生殖及重组生物制品的生物科技公司。
High attention
80.7
/100
- Offer price
- HK$26.38
- Final offer price
- HK$26.38
- Lot / entry fee
- 100 shares · HK$3K
- Proceeds
- HK$1.00B
- Sponsor
- CITIC Securities / Haitong International
- Est. margin oversub.
- 2691.8x
- Public oversub.
- 3526.3x
- One-lot win rate
- 7.0%
- First-day return
- +138.8%
Offer starts
Dec 2
Offer closes
Dec 5
Grey market
Dec 9
Listing
Dec 10
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
80.7/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Strong positivePartial basis
Up probability
94.8%
First-day reference range
+91.5% – +170.9%
Published outcome check
First-day resultBig up+138.8%
Our call: Trend call valid
Covered 14/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Weaker qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Positive trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Weak appealFundamental quality
Average qualityGrowth quality
—Profitability
—Cash runway
Weak qualityCustomer concentration
—Cornerstone quality
—Sponsor record
Strong recordGreenshoe arrangementNo greenshoe
Stabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
Good heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.